Metall Zug AG ( (CH:METN) ) just unveiled an announcement.
Metall Zug AG reported a successful financial year 2024, marked by the profitable launch of the SteelcoBelimed joint venture and strategic advancements in ophthalmology. Despite a decline in net revenue due to divestments and market challenges, the company achieved a significant EBIT increase, driven by the merger profits and strategic investments. The company remains committed to its long-term growth strategy, focusing on innovation and infrastructure development, which is expected to enhance its market position and stakeholder value.
More about Metall Zug AG
Metall Zug AG operates in the industrial sector, focusing on medical technology and infrastructure development. The company is involved in ophthalmological diagnostics through its Haag-Streit division and is engaged in real estate projects, including the Tech Cluster Zug.
YTD Price Performance: 1.80%
Technical Sentiment Signal: Buy
Current Market Cap: $568.2M
For detailed information about METN stock, go to TipRanks’ Stock Analysis page.